Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food

NCT02229838 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBB 1464 MS tablet
DRUG: BIBB 1464 MS solution
DRUG: BIBB 1464 MS placebo
OTHER: Standard dinner

Sponsor

Boehringer Ingelheim